immune system
• mice infected with MERS-CoV intranasally show peribronchiolar inflammation at 2 days post infection
|
• mice infected with MERS-CoV intranasally show lung pathology consistent with development of interstitial pneumonia and lung disease
|
• mice support efficient infection and replication of the human Middle East respiratory syndrome coronavirus (MERS-CoV)
• however, no viral RNA or inflammation is seen in the brain of MERS-CoV infected mice
• mice pretreated with REGN3051 or REGN3048, antibodies which bind to the MERS-CoV receptor-binding domain, show decreased viral levels and lung pathology after infection with MERS-CoV
• mice infected with MERS-CoV and then treated with REGN3051 at 24 hours after infection, show decreased viral levels and lung pathology
|
respiratory system
• mice infected with MERS-CoV intranasally show peribronchiolar inflammation at 2 days post infection
|
• mice infected with MERS-CoV intranasally show lung pathology consistent with development of interstitial pneumonia and lung disease
|
• mice infected with MERS-CoV intranasally develop extensive alveolar septum thickening at 4 dpi
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Middle East respiratory syndrome | DOID:0080642 | J:223728 |